Research ExplorerJournalsONCOLOGY-BASEL Publications

ONCOLOGY-BASEL

1 - 12 out of 12Page size: 50

Publications

  1. 2022

  2. Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study

    Briggs, A., Paracha, N., Rosettie, K., Upton, A., Bokemeyer, C., Lassen, U. & Sullivan, S. D., 2022, In: ONCOLOGY-BASEL. 100, 2, p. 124-130 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2015

  4. Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)

    Niegisch, G., Retz, M., Thalgott, M., Balabanov, S., Honecker, F., Ohlmann, C. H., Stöckle, M., Bögemann, M., Vom Dorp, F., Gschwend, J., Hartmann, A., Ohmann, C. & Albers, P., 07.2015, In: ONCOLOGY-BASEL. 89, 2, p. 70-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2013

  6. Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer

    Mathey, S., Graeser, M. K., Zu Eulenburg, C., Woelber, L., Trillsch, F., Jänicke, F., Müller, V., Milde-Langosch, K. & Mahner, S., 01.01.2013, In: ONCOLOGY-BASEL. 85, 2, p. 69-77 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2012

  8. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.

    Witzel, I., Schröder, C., Müller, V., Zander, H., Tachezy, M., Henningsen, M., Jänicke, F. & Milde-Langosch, K., 2012, In: ONCOLOGY-BASEL. 82, 6, p. 305-312 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2010

  10. Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor.

    Oechsle, K., Lorch, A., Honecker, F., Kollmannsberger, C., Hartmann, J. T., Boehlke, I., Beyer, J. & Bokemeyer, C., 2010, In: ONCOLOGY-BASEL. 78, 1, p. 47-53 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 2008

  12. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.

    Jehan, Z., Siraj, A. K., Abubaker, J., Ruiz, C., Simon, R., Sultana, M., Uddin, S., Bavi, P., Hussain, A., Razack, S., Ezzat, A., Al-Dayel, F., Sauter, G. & Al-Kuraya, K. S., 2008, In: ONCOLOGY-BASEL. 75, 1-2, p. 71-80 1-2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2005

  14. Cancer-related anemia: pathogenesis, prevalence and treatment

    Birgegård, G., Aapro, M. S., Bokemeyer, C., Dicato, M., Drings, P., Hornedo, J., Krzakowski, M., Ludwig, H., Pecorelli, S., Schmoll, H., Schneider, M., Schrijvers, D., Shasha, D. & Van Belle, S., 2005, In: ONCOLOGY-BASEL. 68 Suppl 1, p. 3-11 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?

    Birgegård, G. & Bokemeyer, C., 2005, In: ONCOLOGY-BASEL. 69 Suppl 2, p. 17-21 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. 1999

  17. S100B protein detection in serum is a significant prognostic factor in metastatic melanoma.

    Hauschild, A., Engel, G., Brenner, W., Gläser, R., Mönig, H., Henze, E. & Christophers, E., 1999, In: ONCOLOGY-BASEL. 56, 4, p. 338-344 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 1991

  19. Influence of serum derived from patients with head and neck cancer on natural killer cell activity.

    Kumazawa, H. & Hess, M., 1991, In: ONCOLOGY-BASEL. 48, 5, p. 372-376 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. 1986

  21. Determination of 7-hydroxymethotrexate in human plasma by reversed phase high-performance liquid chromatography.

    Erttmann, R., Bielack, S. & Landbeck, G., 1986, In: ONCOLOGY-BASEL. 43, 2, p. 86-88 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 1984

  23. Prolonged methotrexate infusions in children with acute leukemia in relapse and in remission and with medulloblastoma. Pharmacokinetics, toxicity and clinical results.

    Janka-Schaub, G., Mack, R., Helmig, M., Haas, R. J. & Bidlingmaier, F., 1984, In: ONCOLOGY-BASEL. 41, 4, p. 225-232 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review